1. Twenty-four patients were studied at around 7 days after musculoskeletal injuries in order to define the nature of the impairment of sensitivity to insulin. Insulin was infused at 6, 35, 200 or 1200 m-units min-' m-* for 2 h and the plasma glucose concentration was 'clamped' at 5 mmol/l. Forearm (uninjured) glucose extraction and blood flow were measured, and whole-body substrate oxidation and energy production rates were assessed by indirect calorimetry. The patients were compared with normal control subjects.
INTRODUCTION
The 'catabolic' response after injury is of major clinical importance. The deleterious effects of this response can be ameliorated by appropriate nutritional support, but the basis for this is still largely empirical [l] . An understanding of the underlying metabolic changes is, however, now slowly emerging. Many aspects of the response to injury or sepsis give an impression of loss of sensitivity to the anabolic effects of insulin [2] . Thus, there is an increased rate of fat oxidation which is not suppressed as normal by glucose infusion [3-51, glucose intolerance despite normal or elevated insulin concentrations [5, 61 , and net protein breakdown again despite hyperinsulinaemia.
The glucose intolerance of sepsis and injury reflects in part increased hepatic glucose production, which is not suppressed normally in response to glucose infusion [7- 91, but it also reflects impairment of glucose uptake. This has been shown by glucose clamp experiments, which have demonstrated impaired glucose utilization both by the whole body [S, 61 and by the uninjured muscle of the forearm [lo] . The impaired glucose disposal might in turn be related to the high rate of fat oxidation by the operation of the 'glucose-fatty acid cycle' [ 1 11. It may also be causally related to the net proteolysis, since, at least in experiments in vitro, lack of energy substrate will increase protein breakdown [ 121.
It is therefore important to clarify both the nature of, and the relationships between, these various facets of insulin resistance in the injured patient. However, there have been few such studies. Wilmore and co-workers [6, lo] have studied dose-response relationships for the effects of insulin on whole-body and forearm glucose utilization using euglycaemic-insulin clamp techniques, but the range of insulin concentrations produced, and the number of patients studied at higher rates of insulin infusion, were relatively small, and the patient group was rather heterogeneous.
A related question concerns the nature of the hormonal or nervous stimuli for these responses. Much interest has centred on the demonstration that infusion of a combination of 'counter-regulatory' hormones into normal subjects will reproduce many of the features of the response to injury [13, 141. However, not all patients displaying marked metabolic changes have such raised 'counter-regulatory' hormone concentrations [2, 51, which suggests that other factors may be involved.
We have now attempted to clarify some of these points by detailed study of a fairly homogeneous group of patients who had sustained accidental injuries (long-bone fractures). We have studied the effects of a wide range of insulin concentrations, produced by the euglycaemicinsulin clamp technique, on whole-body and forearm glucose metabolism and on whole-body substrate oxidation. Some of the results have been reported in a preliminary form [ 151 and some form part of a thesis [ 161.
METHODS

Subjects, patients and experimental design
In order to examine dose-response relationships with insulin, subjects were studied on separate occasions with different insulin infusion rates (6, 35, 200 and 1200 m-units min-I m-2). It was not felt possible to study the injured patients on more than one occasion, so 24 separate patients were studied, six at each infusion rate. [In fact, 29 patients (27 male, two female) were studied in total, but some studies were incomplete; numbers for each estimation are given in the Results section.] Their ages ranged from 17 to 42 years (median 24 years), their heights from 1.75 to 1.88 m (median 1.78 m), their weights from 56.5 to 99 kg (median 73 kg) and their body mass indices (weight/height2) from 18.4 to 28.7 kg/m2 (median 22.7 kg/m2). They were compared with 12 normal subjects, four of whom (all male) were studied on separate occasions at least 1 week apart at each of the four infusion rates. Eight other subjects (three male, five female) were each studied at one infusion rate only. The age range of the control subjects was 18-39 years (median 25 years), their height range was 1.50-1.93 m (median 1.74 m), their weight range was 49-86 kg (median 61 kg) and their body mass index range was 19.0-24.9 kg/m2 (median 21.8 kg/m2). The phase of the menstrual cycle was not controlled in the female subjects.
The patients were studied at either Hope Hospital (Salford Health Authority) or Stockport Infirmary (Stockport Health Authority). They had all sustained injuries including at least one long-bone fracture. Their injury severity scores [ 171 ranged from 9 to 43 (median 9). Only one patient (injury severity score 34, studied at 200 munits of insulin min-I m-2, subsequently died from his injuries, in this case from complications of a head injury. Twenty-four hour urine collections for the measurement of nitrogen excretion were started soon after admission. At the time of study, all patients were non-septic as judged by clinical, bacteriological and haematological methods [ 181. Some were receiving paracetamol-based analgesia and those with compound fractures were receiving cephalosporin-based antibiotics; medication was stopped on the evening before the study. They were being offered a standard hospital diet. In 12 representative patients food intake was recorded by a dietician for 3 consecutive days around the time of study; this showed a median intake of 51.5 g of protein/day, 56 g of fat/day and 196 g of carbohydrate/day. Although anthropometric measurements were not made serially in the patients, at the time of study their triceps skinfold thicknesses and mid-arm circumferences were not different from those of the control subjects [16] .
All patients and control subjects gave informed consent, and the protocol was approved by the Ethical Committees of the two health authorities involved.
Protocol
Patients and control subjects were studied after fasting overnight. Studies were carried out in an experimental room, on the orthopaedic wards or in an intensive care unit. Ambient temperatures were between 18 and 22°C. Cannulae were inserted under local anaesthesia into a vein draining the hand, which was then warmed in a box at 60-70°C to provide arterialized blood [ 191, and into an antecubital vein on the same arm for infusion. A contralateral antecubital vein which appeared to be draining deep tissues was cannulated in a retrograde direction to provide samples of forearm muscle drainage. A blood pressure cuff around the wrist on this arm was inflated to 200 mmHg for 2 min before each sample to occlude hand blood flow.
At least 30 min after insertion of the cannulae, blood samples were taken simultaneously from the arterialized and forearm venous sites. Further baseline samples were taken 20 min later. An infusion of human insulin was then started using the priming schedule given by DeFronzo et ul. [20] but scaled in proportion to the chosen insulin infusion rate. The insulin was dissolved in polygeline solution (Haemaccel; Hoechst U.K. Ltd, Hounslow, Middx., U.K.) to prevent adsorption to plastic [21] . A glucose infusion was started at 4 min, and the rate of glucose infusion was then varied during the experiment according to the arterialized plasma glucose concentration, measured at 5 min intervals on a Beckman 2 Glucose Analyser, to maintain a plasma glucose concentration of 5 mmol/l. Samples for measurement of arterio-venous differences and plasma catecholamine concentrations were taken at 20 min intervals during the clamp, and for estimation of plasma glucagon and cortisol levels during the baseline period and at 60 and 120 min.
Forearm blood flow was measured after each sample, in the arm from which deep venous samples were taken, by venous occlusion plethysmography [22] . Forearm glucose uptake was calculated as the product of blood flow and arteriovenous difference, and blood flow and glucose uptake were averaged over 40 min periods within each subject. Whole-body oxygen consumption and carbon dioxide production were measured during the baseline period, and again during the last 30 min of the procedure, using a Sensor-Medics Horizon Metabolic Measurement Cart with a ventilated hood system. Net Table 1 . Basal arterial blood and plasma metabolite and hormone concentrations
Results are means f SEM with n in parentheses. Statistical significance (unpaired t-test): * P < 0.05, **P< 0.001 compared with control subjects.
rates of substrate oxidation were calculated as previously described [23] , using the patient's measured 24 h urinary nitrogen excretion. The mean control value of 6.5 g day-' m-2 (see the Results section) was used for the control subjects. Nitrogen excretion was not measured after the insulin infusion. Substrate oxidation rates at the end of infusion were therefore calculated both using the above values for nitrogen excretion and making the assumption that protein oxidation was completely suppressed; the pattern of results was very similar. Results shown are all based on the measured nitrogen excretion rates. The rate of glucose infusion during the glucose clamp, after correction for changes in plasma glucose concentration (assumed to be distributed throughout the glucose space), provides an estimate of whole-body glucose disposal if endogenous glucose production is assumed to be suppressed [203. Since we did not wish to make this assumption in the injured patients at low rates of insulin infusion, results are presented in terms of whole-body glucose infusion rates, again after correction for changes in glucose pool size (based on changes in plasma glucose concentration). This is referred to as the 'corrected glucose infusion rate'. 2 4 ) 81+15 (26) Acetoacetate (pmol/l) 6 9 f 1 0 ( 2 4 ) 9 5 f 1 3 ( 2 8 ) Glycerol (prnol/l) 45 k 5 (24) 44k2 ( 
Analytical methods
Analytical methods were as previously described [ 51 except that the fluorometric enzymatic assays for blood and plasma metabolites were carried out on a Cobas Bio centrifugal analyser (Roche Diagnostics, Welwyn, Herts, U.K.) using methods similar to those described by Harrison et al. [24] . Urinary nitrogen was measured by an automated Kjeldahl procedure [25] .
Statistical analysis
Results are presented as means f SEM. The significance of differences between means was assessed both by Student's t-test and by Wilcoxon's non-parametric test. In every case similar levels of sigmficance were found, and only the results of t-tests are presented. ( n = 8 ) 
RESULTS
Fasting values
Catabolic state of the patients. Mean 24 h urinary nitrogen excretion at the time of study was 11.1 k 1.1 g/m*, compared with 6.5k0.7 g/m2 in five control subjects who provided urine samples (P<O.025). In the 12 patients whose food intake was monitored, mean nitrogen balance was negative in all but one ( -5.3 k 1.5 g day-' m-2; P < O . O O l by paired t-test). Arterial metabolite and hormone concentrations, and indirect calorimetry. Basal blood and plasma metabolite and hormone concentrations for all patients are compared with those for control subjects in Table 1 . The patients showed hyperinsulinaemia but no significant hyperglycaemia, and small but significant elevations in plasma concentrations of cortisol, glucagon and noradrenaline. Resting energy expenditure ( Table 2) was increased by 13% compared with control subjects, carbohydrate oxidation was decreased by 36% (not significant) and fat oxidation was increased by 5 1% (not significant).
Forearm metabolism. Forearm blood flow in the basal state was significantly greater in the patients (3.3 k 0.3 ml rnin-l 100 ml-l of tissue) than in the control subjects (2.5k0.2 ml min-l 100 ml-l of tissue) (P<O.O5 by unpaired t-test).
Forearm glucose uptake in the basal state was greater in the control subjects (0.78 k0.15 pmol min-I 100 ml-' of tissue) than in the patients (0.01 k0.19 pmol min-l 100 ml-I of tissue) ( P < 0.01 by unpaired t-test). In the control subjects forearm glucose uptake was significantly greater than zero (P<O.001 by paired t-test), whereas in the patients it was not.
Effects of insulin infusion
Insulin and control of glycaemia. Mean plasma insulin concentrations achieved during the four rates of infusion are shown in Table 3 . They were very similar in patients and control subjects. The metabolic clearance rates for insulin (calculated as the rate of infusion divided by the increase in concentration above basal) were therefore also similar ( Table 3) . Control of glycaemia was better at lower infusion rates (Table 4) , and better in patients than in control subjects; even at the highest infusion rates mean coefficients of variation of plasma glucose concentration were < 10% in control subjects and < 5% in patients.
The 'corrected glucose infusion rates' needed to maintain euglycaemia (corrected for changes in glucose pool size, as described in the Methods section) are shown in Table 4 . Dose-response curves were constructed by plotting the mean 'corrected glucose infusion rate' over the last 80 min of the clamp against the individual's own mean insulin concentration over the same period (Fig. 1) . They show a clear difference in sensitivity to insulin (insulin concentration for half-maximal stimulation 90 m-units/l in control subjects, 320 m-units/l in patients), with a diminished maximal response in the patients. Arterial concentrations of other intermediary metabolites and hormones. Arterial plasma concentrations of non-esterified fatty acids, glycerol and ketone bodies, which were not significantly different in patients and control subjects in the fasting state, all fell on infusion of insulin, with the smallest fall at the lowest infusion rate. There were no significant differences between the patients and control subjects for any of these metabolites at any stage of infusion, and in fact most of the timecourses for control subjects and patients were virtually superimposable (results not shown).
Plasma concentrations of cortisol and catecholamines did not change with insulin infusion at any rate in either group (Table 5) . Plasma glucagon concentrations fell during the two higher rates of insulin infusion in the patients only, bringing them to values similar to the control subjects (Table 5) .
Indirect calorimetry. Because indirect calorimetry could not be performed on the two patients studied at Stockport Royal Infirmary, and was omitted from some other studies for technical reasons or poor tolerance, the number of patients studied at individual infusion rates was limited (for the infusion rates 6, 35, 200 and 1200 m-units of insulin min-' m-2, n = 4 , 3, 5 and 4, respectively, for injured patients; n = 4, 6, 6 and 5, respectively, for control subjects). The results at the two lower rates and at the two higher rates were not apparently different from each other, and so have been combined.
At infusion rates of 200 and 1200 m-units of insulin h-1 m-*, resting energy expenditure increased during insulin infusion in the control subjects (Table 2 ). In the patients, the resting energy expenditure, which was greater than in the control subjects in the fasting state, did not increase significantly during insulin infusion at any rate, and final values for energy expenditure were similar in the two groups. The respiratory exchange ratio rose during insulin infusion at higher infusion rates in both control subjects and patients, but more so in the control subjects (Table 2) . Carbohydrate oxidation was stimulated by insulin infusion in the control subjects at all infusion Fig. 1 . Dose-response curves for the effect of insulin on whole-body glucose infusion rate necessary to maintain euglycaemia (equal to whole-body glucose uptake rate if hepatic glucose production is suppressed) in injured patients ( 0 ) and control subjects (0). Each point represents the result of an individual euglycaemic clamp study. The glucose infusion rate and the insulin concentration shown are each averaged over the last 80 min of the clamp procedure.
Table 5. Changes in plasma hormone concentrations during insulin infusion
Results are means k SEM ( n = 3-7 per group). Measurements were made before insulin infusion and after 2 h of insulin infusion at the rate shown. Statistical sigmficance: *P< 0.05, **P< 0.001 for after infusion versus before infusion (paired ttest); tP< 0.05 for injured patients versus control subjects (unpaired t-test). For si@cance of differences in values before infusion over all subjects, see Table 1 . Table 6 . Forearm blood flow and forearm glucose uptake Results are means k SEM ( n = 5-6 per group). Statistical significance (unpaired r-test): * P < 0.05 compared with control subjects. Overall mean basal blood flow and glucose uptake were significantly different (see the text).
rates, and fat oxidation decreased at the higher rates. In the injured patients, carbohydrate oxidation increased and fat oxidation fell at the higher infusion rates, but not to the same extent as in control subjects, so that the final rate of carbohydrate oxidation during the 200 and 1200 m-units of insulin min-I m -* infusions was only 41% of that in the control subjects, and the final rate of fat oxidation was considerably greater than in the control subjects. Forearm metabolism. There were no differences in forearm blood flow between patients and control subjects (Table 6 ). Forearm glucose uptake was increased in the control subjects on infusion of insulin at all but the lowest rate. In the patients glucose uptake was not increased by 6 or 35 m-units of insulin min-' m-2. Glucose uptake in the injured patients was lower than that in the control subjects at all infusion rates (Table 6) .
Dose-response curves were constructed by plotting the mean forearm glucose uptake over the last 80 min for each subject, against his own mean insulin concentration over the same period (Fig. 2) . As in the case of the wholebody infusion rate, there was a reduction in the patients in both sensitivity and maximal response; the insulin concentration for half-maximal stimulation was 100 m-units/] in the control subjects (similar to the value for glucose infusion rate to maintain normoglycaemia) and around 500 m-units/] (but not accurately determinable) in the patients.
There was a relationship between forearm glucose uptake and whole-body 'corrected glucose infusion rate' needed t o maintain euglycaemia, as found by YkiJarvinen et al. [26] for forearm glucose uptake and wholebody glucose utilization. The relationship appeared to be the same in both control subjects and patients (Fig. 3) , although the spread of values was inevitably less in the patients.
DISCUSSION
The glucose intolerance associated with injury has been recognized for many years. Within the last decade it has been explored using techniques such as the glucose clamp, measurement of arteriovenous differences across muscle beds, and tracer experiments. Such an approach is necessary in order to understand the mechanism of this response to injury, and eventually modify it, together, hopefully, with the clinical sequelae of catabolism and muscle wasting. However, the picture emerging has not been entirely clear. This is undoubtedly due, at least in part, to the heterogeneity of the groups of injured patients studied and the inclusion of sepsis and malnutrition as part of the picture in some studies.
We have previously identified a fairly homogeneous group of injured patients [27] , typical of large numbers seen in the orthopaedic wards and intensive care units in the U.K. These patients show no clinical or laboratory evidence of sepsis; they are usually young or middle-aged previously healthy people, and malnutrition is not evident at the time of their peak responses (increased urinary nitrogen excretion and hyperinsulinaemia) around 1 week after their injury. They are, nevertheless, sufficiently Forearm glucose uptake (mgmin-' lOOml-' oftissue) Fig. 3 . Relationship between whole-body glucose infusion rate (as shown in Fig. 1 ) and forearm glucose uptake (as shown in Fig. 2 ) in injured patients ( 0 ) and control subjects (0). Each point represents the result of an individual euglycaemic clamp study. In both cases the relationship is significant at P<O.OOl by Kendall's rank correlation test.
severely injured to display a marked catabolic response much as described by Cuthbertson [28] more than 50 years ago; typically around 2 kg of lean body mass will be lost during the first few weeks after their injuries [27] . These patients appear to differ in several respects from those studied in the U.S.A., whose injures often include penetrating wounds and in whom sepsis is often a complication.
We were thus able to recruit sufficient patients to build up complete dose-response curves to insulin. We found it necessary to reach much higher concentrations of insulin than in previous studies [6, 101 in order to demonstrate convincingly that maximal responses had been achieved. From these dose-response curves for both forearm glucose uptake and whole-body 'corrected glucose infusion rate' necessary to maintain normoglycaemia, it was clear that the injured patients displayed considerable impairment of both sensitivity to insulin (concentration for half-maximal effect) and maximal responsiveness [29] . This suggests changes in both receptor binding of insulin and in intracellular pathways [29] . The relationship between forearm glucose uptake and whole-body 'corrected glucose infusion rate' (Fig. 3) suggests that, at higher concentrations of insulin, the whole-body infusion rate is a measure of whole-body glucose utilization. This is expected in normal subjects in whom insulin infusion will suppress hepatic glucose production [30] . In injured patients, suppression of glucose production at lower insulin concentrations may be less complete [3, 6] , but the dose-response curves for whole-body 'corrected glucose infusion rate' in the normal control subjects and the patients showed no sign of convergence at higher insulin concentrations, implying a real difference in the maximal responsiveness to insulin of their whole-body glucose disposal. Furthermore, the lack of complete suppression of glucose production by insulin in injured patients is thought to be due to high levels of 'counter-regulatory' hormones [ 141; our patients, as will be discussed further below, displayed much lower levels of the 'counter-regulatory' hormones than did those in other studies [3] .
Our other measurements provided some clues as to the mechanism of the impairment of muscle glucose uptake. Resting energy expenditure was increased in the fasting state mainly as a result of increased fat oxidation. During insulin infusion energy expenditure changed little in the patients, whereas it increased in the control subjects, reflecting an increasing rate of carbohydrate oxidation; this was seen to a lesser extent in the patients. This sustained fat mobilization and oxidation might well be associated with impaired insulin responsiveness in muscle, through the mechanism of the 'glucose-fatty acid cycle' [ll] . Such a mechanism is increasingly being suggested as a cause of impaired sensitivity to insulin in obesity and non-insulin-dependent diabetes [31] . As in septic patients [5] , the increased rate of whole-body fat oxidation after injury was not reflected in any difference in plasma non-esterified fatty acid levels. Whether the derivation of an increased proportion of resting energy expenditure from fat is in itself deleterious, or whether it simply reflects a generalized unresponsiveness to the hyperinsulinaemia seen in these patients, is not clear. Clinical evidence for the efficacy of intravenous fat emuisions in sparing protein breakdown [32] suggests the latter.
It has been suggested that the unresponsiveness of (net) protein catabolism to the restraining effect of hyperinsulinaemia, the continuing mobilization and oxidation of fat, and the impairment of glucose tolerance seen after injury represent a general picture of 'insulin resistance'; our results show that, whilst these phenomena might be closely inter-related, they do not result simply from a change in insulin binding. Another suggestion is that the 'catabolic' changes after injury result from the elevated levels of 'counter-regulatory ' hormones found in such patients. Infusion of glucagon, cortisol and adrenaline, with or without noradrenaline, into normal subjects produces metabolic effects similar to those seen after injury [13, 141 . However, as we have pointed out previously in a study of septic patients, marked metabolic changes may be present in patients in whom, as in the present study, levels of 'counter-regulatory' hormones, although elevated, are well below those reached in infusion experiments [2, 5] .
The response to injury as investigated here undoubtedly represents the combination of many factors, such as immobility, partial starvation, metabolic demands of the wound and endogenous 'counter-regulatory' hormone and cytokine responses [2] . It is interesting, however, that the first two of these would be expected to decrease metabolic rate, and the increased energy expenditure of injured patients should thus be seen as occurring despite these factors [2] .
The ultimate aim of studies such as these must be, through an increased understanding of the metabolic responses to injury, to improve patient care and acceler-ate rehabilitation. Such a goal is still distant. At a practical level, our studies do show once again the need of even these 'routine' injured patients for nutritional care. They also emphasize the usefulness of fat emulsions as an energy source; glucose will, even in the presence of large amounts of insulin, be poorly utilized.
